Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion
Puneet Souda

Puneet Souda Analyst Performance

Senior Research Analyst at Leerink Partners

Puneet Souda is a stock analyst at Leerink Partners focused in the medical sector, covering 17 publicly traded companies. Over the past year, Puneet Souda has issued 10 stock ratings, including buy and hold recommendations. While full access to Puneet Souda's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Puneet Souda's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
38 Last 9 Years
Buy Recommendations
89.47% 34 Buy Ratings
Companies Covered
17 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy89.5%34 ratings
Hold10.5%4 ratings
Sell0.0%0 ratings

Out of 38 total stock ratings issued by Puneet Souda at Leerink Partners, the majority (89.5%) have been Buy recommendations, followed by 10.5% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
82.4% of companies on NASDAQ
14 companies
NYSE
17.6% of companies on NYSE
3 companies

Puneet Souda, an analyst at Leerink Partners, currently covers 17 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
15 companies
88.2%
Manufacturing
1 company
5.9%
Transportation
1 company
5.9%

Puneet Souda of Leerink Partners specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Transportation companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
7 companies
41.2%
MED INSTRUMENTS
4 companies
23.5%
LAB ANALYTICAL INSTRUMENTS
1 company
5.9%
TRANS - SERVICES
1 company
5.9%
MED PRODUCTS
1 company
5.9%
MED - DRUGS
1 company
5.9%
SURGICAL & MEDICAL INSTRUMENTS
1 company
5.9%
MEDICAL LABORATORIES
1 company
5.9%

About Puneet Souda

Puneet Souda is a Senior Research Analyst at Leerink Partners covering Life Science Tools and Diagnostics. His research focuses on companies and technologies within the Life Science Tools subsector, the Diagnostics subsector, and selected areas of Pharmaceutical Services. Prior to joining the Firm in 2014, Puneet was a Senior Associate at Citigroup covering Medical Devices. Before joining Wall Street, he spent over a decade in core and basic research labs at UCLA and Purdue University. In this work, he was a customer and collaborator of many Life Science Tools and Diagnostic companies. Puneet has direct experience in the acquisition, management, and utilization of many life sciences technologies for molecular analysis and diagnostics. He has co-authored over 45 peer-reviewed scientific papers and has built an extensive network of colleagues and collaborators among academic lab researchers and Life Science Tools suppliers. He earned an M.B.A. from University of California-San Diego and undertook graduate study in biotechnology and earned a B.A. in Biology from Purdue University.
Follow on LinkedIn

Puneet Souda's Ratings History at Leerink Partners

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
ALMR
Alamar Biosciences
5/12/2026Initiated Coverage$23.88$35.00Outperform
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
5/5/2026Upgrade$56.19$70.00Outperform
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
4/29/2026Upgrade$9.02$25.00Outperform
Guardant Health, Inc. stock logo
GH
Guardant Health
2/20/2026Boost Price Target$103.10$180.00Outperform
Guardant Health, Inc. stock logo
GH
Guardant Health
12/15/2025Boost Price Target$103.72$155.00Outperform
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
10/22/2025Boost Price Target$568.42$580.00Outperform
Hologic, Inc. stock logo
HOLX
Hologic
10/21/2025Boost Price Target$74.04$78.00Market Perform
Guardant Health, Inc. stock logo
GH
Guardant Health
9/25/2025Boost Price Target$61.55$75.00Outperform
CryoPort, Inc. stock logo
CYRX
CryoPort
8/6/2025Upgrade$6.74$16.00Outperform
908 Devices Inc. stock logo
MASS
908 Devices
8/5/2025Upgrade$6.27$12.00Outperform
Quanterix Corporation stock logo
QTRX
Quanterix
4/30/2025Reiterated Rating$6.05$8.00Market Perform